A randomised open controlled parallel group multicenter study to evaluate the efficacy and safety of Norspan versus Tiparol Retard in subjects with chronic moderate to severe OA pain of the hip and/or knee

Trial Profile

A randomised open controlled parallel group multicenter study to evaluate the efficacy and safety of Norspan versus Tiparol Retard in subjects with chronic moderate to severe OA pain of the hip and/or knee

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Buprenorphine; Tramadol
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 25 Jun 2007 Status changed from initiated to completed.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top